NLRC4 and breast carcinoma: The KMPlot analysis41 indicated that NLRC4 mRNA was inversely associated with overall survival in all breast cancer patients and even more so in ER+ luminal breast cancers (Fig. 7e, left two panels), indicating that NLRC4 is a marker for poor prognosis.